Presentation is loading. Please wait.

Presentation is loading. Please wait.

Michael Panzer, MD ThedaCare Behavioral Health

Published byPhilomena Norris Modified over 6 years ago

Similar presentations

Presentation on theme: "Michael Panzer, MD ThedaCare Behavioral Health"— Presentation transcript:

1 Michael Panzer, MD ThedaCare Behavioral Health
DEPRESSION Michael Panzer, MD ThedaCare Behavioral Health

2 PEARLS SCREEN FOR BIPOLAR HIGH RECURRENCE RISK THERAPY LIFESTYLE

3 HOW WILL YOU APPLY THIS TALK TO YOUR PRACTICE?

4

5 SYMPTOMS OF DEPRESSION
DEPRESSED MOOD OR PLEASURE CHANGE IN APPETITE / WEIGHT CHANGE IN SLEEP PSYCHOMOTOR CHANGE

6 …SYMPTOMS FATIGUE WORTHLESSNESS OR GUILT DECREASED CONCENTRATION MORBID THOUGHTS

7 …SYMPTOMS (NON-DSM) CRYING NEEDLESS WORRY IRRITABILITY WITHDRAWAL DIURNAL PATTERN

8 NATURAL HISTORY AGE IF GOES UNTREATED… SUICIDE BECOMES HARDER TO TREAT

9 RECURRENCE RISK 1 EPISODE: 50 % OLDER ONSET RESIDUAL SX RISKS FROM RECURRENCE

10 MDQ MOOD SLEEP PAINFUL CONSEQUENCES
MANIA MDQ MOOD SLEEP PAINFUL CONSEQUENCES

11 ANTIDEPRESSANTS MAOIs TCAs SSRIs SNRIs

12 SSRIs fluoxetine paroxetine fluvoxamine citalopram sertraline escitalopram

13 SSRI STRATEGIES START LOW, GO SLOW PATIENCE DO NOT STOP SUDDENLY BROAD SPECTRUM

14 OTHER ANTIDEPRESSANTS
MIRTAZAPINE NEFAZODONE VILAZODONE VORTIOXETINE

15 ANXIETY AND DEPRESSION
EACH TENDS TO CAUSE THE OTHER USEFUL TO KNOW WHICH IS PRIMARY

16 DSM 5 ANXIETY FAREWELL: OCD, PTSD, ASD, OVERANXIOUS WELCOME: MUTISM SEPARATION ANXIETY

17 DSM 5 ANXIETY PANIC AND AGORAPHOBIA GENERALIZED ANXIETY SOCIAL ANXIETY DISORDER (OCD) PHOBIAS (PTSD, ASD)

18 BENZODIAZEPINES CLONAZEPAM 0.25-0.5 mg ALPRAZOLAM 0.5 mg LORAZEPAM 1.0 mg DIAZEPAM 5-10 mg

19 BENZODIAZEPINE RISKS DEPENDENCE ABUSE WITHDRAWAL PSYCHOMOTOR IMPAIRMENT COGNITION SEDATION

20 DOCUMENTATION – BZs driving alcohol collateral sources patient tolerance alternatives tried PDMP mad relatives

21 OTHER ANXIOLYTICS. HYDROXYZINE
OTHER ANXIOLYTICS *HYDROXYZINE *BUSPIRONE GABAPENTIN PREGABALIN ATYPICALS? PROPRANOLOL *approved

22 LITHIUM Excellent stabilizer, some antidepressant effect
Lowers the risk of suicide! (do not stop suddenly) Narrow therapeutic window, levels important Renal, thyroid, GI, tremor, thirst, weight Interactions (NSAIDS, diuretics, ACE inhibitors) Avoid dehydration TSH, creatinine, 12-hour level, (calcium)

23 LAMOTRIGINE (Lamictal)
Anticonvulsant More antidepressant than antimanic Like an antidepressant that does not destabilize Well-tolerated (HA, rash) Slow No labs (+/- level) Interactions: valproic acid, CBZ, estrogen

24 QUETIAPINE (Seroquel)
Atypical antipsychotic Robust antidepressant and antimanic activity Sleep / sedation, weight gain, metabolics EPS, TD, dizziness Baseline fasting labs, 3m and yearly, and discussion of metabolic effects

25 ARIPIPRAZOLE (Abilify)
Atypical antipsychotic Unipolar depression (adjunct) Mania and mixed Nonapproved use for bipolar depression Some potential for sedation and weight gain EPS, TD, dizziness Baseline fasting labs, 3m and yearly, and discussion of metabolic effects

26 EXERCISE WORK FINANCES MEDICAL
LIFE FACTORS EXERCISE WORK FINANCES MEDICAL

27 THERAPY CBT MINDFULNESS EXPOSURE MARITAL

28 DON’T DO TOO MUCH CONSIDER MAJOR STRESSORS CAREFUL ABOUT DOSES NOT TOO MANY MEDICATIONS CONSIDER YOUR LIMITS CONSULT

Download ppt "Michael Panzer, MD ThedaCare Behavioral Health"

Similar presentations

Psychopharmacology. Incorrect assumptions Patient is triaged as psychiatric, therefore patient is psychiatric. Patient has a history of psychiatric presentations,

Psychopharmacology. Incorrect assumptions Patient is triaged as psychiatric, therefore patient is psychiatric. Patient has a history of psychiatric presentations,
Guy Brookes Leeds PFT.  Antipsychotic Medication  Antidepressant Medication  Mood Stabilisers  What does the Evidence mean?

Guy Brookes Leeds PFT.  Antipsychotic Medication  Antidepressant Medication  Mood Stabilisers  What does the Evidence mean?
GENERALIZED ANXIETY DISORDER IN PRIMARY CARE Curley Bonds, MD Medical Director Didi Hirsch Mental Health Services Professor & Chair Charles R. Drew University.

GENERALIZED ANXIETY DISORDER IN PRIMARY CARE Curley Bonds, MD Medical Director Didi Hirsch Mental Health Services Professor & Chair Charles R. Drew University.
for the Psychiatry Clerkship is proud to present And Now Here Is The Host... Insert Name Here.

for the Psychiatry Clerkship is proud to present And Now Here Is The Host... Insert Name Here.
Treating Depression in the Primary Care Setting Pharmacologic Interventions Presented by: Jonathan Betlinski, MD Date: 09/25/2014.

Treating Depression in the Primary Care Setting Pharmacologic Interventions Presented by: Jonathan Betlinski, MD Date: 09/25/2014.
Treating Bipolar Disorder in the Primary Care Setting

Treating Bipolar Disorder in the Primary Care Setting
Claudia L. Reardon, MD Assistant Professor University of Wisconsin School of Medicine and Public Health NAMI Wisconsin Annual Meeting April 24, 2015.

Claudia L. Reardon, MD Assistant Professor University of Wisconsin School of Medicine and Public Health NAMI Wisconsin Annual Meeting April 24, 2015.
By: Karli, Storm & Dylan. Bipolar Disorder is a condition where people go back and forth between periods of a very good or irritable mood. The mood swings.

By: Karli, Storm & Dylan. Bipolar Disorder is a condition where people go back and forth between periods of a very good or irritable mood. The mood swings.
2007. Statistics  2-4 new cases per 100,000/year  1 in 200 people will have an episode of hypomania  Peak age of onset 25-30 yrs  May have had a previous.

2007. Statistics  2-4 new cases per 100,000/year  1 in 200 people will have an episode of hypomania  Peak age of onset yrs  May have had a previous.
Depression Ibrahim Sales, Pharm.D. Associate Professor of Clinical Pharmacy King Saud University

Depression Ibrahim Sales, Pharm.D. Associate Professor of Clinical Pharmacy King Saud University
Bipolar Disorders.

Bipolar Disorders.
Major Depressive Disorder Presenting Complaints

Major Depressive Disorder Presenting Complaints
Bipolar Disorder Discussion

Bipolar Disorder Discussion
Pharmacotherapy of Functional Mental Illness in the Elderly. Virupakshi Jalihal Locum Consultant Psychiatrist Cornwall Partnership NHS Foundation Trust.

Pharmacotherapy of Functional Mental Illness in the Elderly. Virupakshi Jalihal Locum Consultant Psychiatrist Cornwall Partnership NHS Foundation Trust.
CASE VIGNETTE: Layla is 31 year old female. She came to your clinic complaining of fearfulness, palpitations, shortness of breath and impaired concentration.

CASE VIGNETTE: Layla is 31 year old female. She came to your clinic complaining of fearfulness, palpitations, shortness of breath and impaired concentration.
Psychopharmacology – A brief introduction. Objectives Review general categories of psychiatric disorders Review general categories of psychiatric disorders.

Psychopharmacology – A brief introduction. Objectives Review general categories of psychiatric disorders Review general categories of psychiatric disorders.
Bipolar I Disorder Treatment. Therapeutic Goals Relief of immediate symptoms Improvement of patient’s well-being Elimination of stressors Combined pharmacotherapy.

Bipolar I Disorder Treatment. Therapeutic Goals Relief of immediate symptoms Improvement of patient’s well-being Elimination of stressors Combined pharmacotherapy.
Schizophrenia 1 month of at least two of the following: delusions hallucinations disorganized speech disorganized behavior negative symptoms positive/psychosis.

Schizophrenia 1 month of at least two of the following: delusions hallucinations disorganized speech disorganized behavior negative symptoms positive/psychosis.
Bambi A. Carkey DNP,PMHNP-BC,NPP Clinical Assistant Professor SUNY Upstate Medical University College of Nursing An Overview of Psychiatric Disorders Commonly.

Bambi A. Carkey DNP,PMHNP-BC,NPP Clinical Assistant Professor SUNY Upstate Medical University College of Nursing An Overview of Psychiatric Disorders Commonly.
Pharmtech review: Anxiety Drugs. AntiAnxiety Drugs Characterized by worry and apprehension For controlling stress Addictive liability very high Birth.

Pharmtech review: Anxiety Drugs. AntiAnxiety Drugs Characterized by worry and apprehension For controlling stress Addictive liability very high Birth.

Similar presentations

Ads by Google